Gajanayaka, N.D.; Jo, E.; Bandara, M.S.; Marasinghe, S.D.; Bawkar, C.; Lee, Y.-J.; Park, G.-H.; Oh, C.; Lee, Y.
Characterisation of High Alkaline-Tolerant Novel Ulvan Lyase from Pseudoalteromonas agarivorans: Potential Applications of Enzyme Derived Oligo-Ulvan as Anti-Diabetic Agent. Mar. Drugs 2024, 22, 577.
https://doi.org/10.3390/md22120577
AMA Style
Gajanayaka ND, Jo E, Bandara MS, Marasinghe SD, Bawkar C, Lee Y-J, Park G-H, Oh C, Lee Y.
Characterisation of High Alkaline-Tolerant Novel Ulvan Lyase from Pseudoalteromonas agarivorans: Potential Applications of Enzyme Derived Oligo-Ulvan as Anti-Diabetic Agent. Marine Drugs. 2024; 22(12):577.
https://doi.org/10.3390/md22120577
Chicago/Turabian Style
Gajanayaka, Navindu Dinara, Eunyoung Jo, Minthari Sakethanika Bandara, Svini Dileepa Marasinghe, Chinmayee Bawkar, Yeon-Ju Lee, Gun-Hoo Park, Chulhong Oh, and Youngdeuk Lee.
2024. "Characterisation of High Alkaline-Tolerant Novel Ulvan Lyase from Pseudoalteromonas agarivorans: Potential Applications of Enzyme Derived Oligo-Ulvan as Anti-Diabetic Agent" Marine Drugs 22, no. 12: 577.
https://doi.org/10.3390/md22120577
APA Style
Gajanayaka, N. D., Jo, E., Bandara, M. S., Marasinghe, S. D., Bawkar, C., Lee, Y.-J., Park, G.-H., Oh, C., & Lee, Y.
(2024). Characterisation of High Alkaline-Tolerant Novel Ulvan Lyase from Pseudoalteromonas agarivorans: Potential Applications of Enzyme Derived Oligo-Ulvan as Anti-Diabetic Agent. Marine Drugs, 22(12), 577.
https://doi.org/10.3390/md22120577
